Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
about
Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathiesCardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population.Role of cardiac MRI in the assessment of nonischemic cardiomyopathiesClinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathyMyofibroblasts: trust your heart and let fate decide.2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theLate Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.Role of Cardiac MR Imaging in CardiomyopathiesLeft Ventricular Speckle Tracking-Derived Cardiac Strain and Cardiac Twist Mechanics in Athletes: A Systematic Review and Meta-Analysis of Controlled StudiesMyocardial fibrosis in congenital and pediatric heart diseaseUtility of magnetic resonance imaging in the evaluation of left ventricular thickening.Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future PossibilitiesCardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.High Spatial Resolution Cardiovascular Magnetic Resonance at 7.0 Tesla in Patients with Hypertrophic Cardiomyopathy - First Experiences: Lesson Learned from 7.0 Tesla.2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology.Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications.Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies.Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes.The role of cardiovascular magnetic resonance in pediatric congenital heart diseaseLeft ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.Aborted sudden cardiac death (SCD) in a patient with hypertrophic cardiomyopathy (HCM) with low-risk factors for SCD.Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic CardiomyopathyPrediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.Ex-vivo Assessment of Coronary Artery Atherosclerosis by Magnetic Resonance Imaging: Correlation with Histopathology.Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathyPatterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion studyIn vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.Hypertrophic cardiomyopathy: infants, children, and adolescents.High-resolution 3-dimensional late gadolinium enhancement scar imaging in surgically corrected Tetralogy of Fallot: clinical feasibility of volumetric quantification and visualization.ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
P2860
Q26765173-FD6F68D7-8EBA-4BD8-A900-509CCE20A810Q26767019-067D8E50-6495-4E1A-B705-B550346BC7D5Q26998997-291F7B9D-A1F1-43CA-B5B3-B4F03F7190F4Q26999424-5EA0A840-9180-4B71-AB0C-2D7CA64E6804Q27692541-7D6DC3A4-56B9-4D70-B62F-B0C6EFFB8E97Q28087002-30C62135-20F1-4234-91FD-0D7ABF834D86Q30251600-685786FB-14FB-4E4F-8961-5813F02BA70DQ30278892-70D36666-FB18-40F9-B7D5-42C998ABD6C5Q30279246-1959DBEB-3991-4470-BFE5-CB6CD9B1F798Q30355534-473BAC68-1EC9-411A-9B3C-D11FB97CABA7Q30355582-947D61D8-0DAD-4327-B43F-A105AD5281C1Q30359543-A8B09A56-0D0B-46E3-B419-EF6B412B382CQ30360334-55DAABCE-D6B4-4831-896F-D85666B78F0FQ30371882-93EBFD55-69D4-49C1-88A5-0558E1B0B972Q30376835-E396275D-5D7D-443C-A506-0FC8FD70D918Q30390279-A0B45253-5EF6-4534-A146-89EE374CF03BQ30423759-FAC6AA86-4908-4094-8642-1333CFA410C3Q30432349-C7D21079-8C19-41CA-BC08-CC7136813810Q30446792-E17A4009-2E6D-4131-B0C9-68E8D59C9C22Q30463822-F5CAC2BC-5D20-4457-A94C-376C397B350EQ30467896-13E45625-5573-4491-A013-D1907492B6B9Q30473136-55C2AF1F-9DE0-4577-892D-E4633B8DB397Q30867239-DFC9F797-17CD-4294-9DDC-B1A65A4987EBQ33162285-CC87160D-804A-4D13-9327-328514FC1FFEQ33162387-773D2757-EA69-40FD-BBDE-15000DBD5089Q33165645-5559EC8F-9A20-4C9E-8111-74C02B46702DQ33166075-E27B5087-0195-4366-B5AB-B8C2480F8E74Q33168755-04048717-D95B-4CB9-A270-169EA5B4852AQ33612030-9A032385-724A-458C-984F-04621D430DC4Q33764571-84909A2A-7195-4C9D-AA81-1BF79669876CQ33855587-3632C597-B642-40B0-A123-E811AC26F22EQ33895261-A1BF4101-8F0D-4743-80D9-F4359BC2E2BFQ34014152-3E8C63B3-D6F1-454F-A3F1-70FEF40C3C20Q34028344-963A4D61-8339-428B-9262-023117A5EB37Q34091933-C7E79350-7E86-419A-8690-A7B8916C0C11Q34123466-AA0ED876-7256-45AB-A901-FBF79F74AE96Q34130016-E62363FF-A660-48EF-BB2E-7698ABD753C5Q34244943-696597F8-A5CB-4F32-A17D-1BFDEFD06A8CQ34271246-96374271-1D6E-4B9C-A1A4-6ACFB91111A9Q34304394-9F15C43C-9213-4773-BD89-2782F8871D5D
P2860
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
@en
type
label
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
@en
prefLabel
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
@en
P2093
P50
P1476
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy
@en
P2093
Agata Grasso
Badri Chandrasekaran
Dana Dawson
Ferdinando Pasquale
Jessica Webb
Leena Sulaibeekh
Meghana Kulkarni
Michael Roughton
Perry M Elliott
Ricardo Wage
P304
P356
10.1016/J.JACC.2010.05.010
P407
P577
2010-06-25T00:00:00Z